Lledo, D. S., Gupta, A., Rossi, C., Burbage, S., Diaz, L., Wong, G., Pilon, D., Khilfeh, I., Morgans, A. K. (2025). Time burden and healthcare costs associated with docetaxel in patients with metastatic castration-sensitive prostate cancer (mCSPC) initiating an androgen receptor pathway inhibitor (ARPI) –based regimen.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.58